This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Retailers file US antitrust claims against Teva over Copaxone

( April 3, 2025, 23:31 GMT | Official Statement) -- MLex Summary: Walgreen, The Kroger, Albertsons Companies, and H-E-B filed a US complaint accusing Teva Pharmaceuticals of illegally delaying a generic competitor for multiple sclerosis treatment drug Copaxone. According to the complaint, Teva delayed competition from Mylan by, among other things, abusing the regulatory and court processes and preventing uptake of Mylan’s bioequivalent product after it finally launched.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections